EUVIMEDAtrasti EUVIMED
Video/Audio

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Cheng-Yang Zhang, Xiao-Feng Zhang, Jun Yuan, Yuan-Feng Gong, Hui Tang, Wan-Yu Guo, Tong-Yan Li, Cai-Wen Li, Yun-Qiang Tang, Ning-Fang Ma, Ming Liu

Journal of Visualized Experiments · 2023

DOI: 10.3791/65785 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Cheng-Yang Zhang and 10 co-authors. Institution: Affiliated Cancer Hospital and Institute of Guangzhou Medical University; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modi…. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 1 times so far (Crossref); 13 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal tumor worldwide and its late discovery and lack of effective specific therapeutic agents necessitate further research into its pathogenesis and treatment. Organoids, a novel model that closely resembles native tumor tissue and can be cultured in vitro, have garnered significant interest in recent years, with numerous reports on the development of organoid models for liver cancer. In this study, we have successfully optimized the procedure and established a culture protocol that enables the formation of larger-sized HCC organoids with stable passaging and culture conditions. We have comprehensively outlined each step of the procedure, covering the entire process of HCC tissue dissociation, organoid plating, culture, passaging, cryopreservation, and resuscitation, and provided detailed precautions in this paper. These organoids exhibit genetic similarity to the original HCC tissues and can be utilized for diverse applications, including the identification of potential therapeutic targets for tumors and subsequent drug development.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansDrug DiscoveryDrug DevelopmentOrganoids

Authors and institutions

  • Affiliated Cancer Hospital and Institute of Guangzhou Medical University; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational…
  • Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University.
  • Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University.

Cite

APA

Zhang, C. Y., Zhang, X. F., Yuan, J., Gong, Y. F., Tang, H., Guo, W. Y., Li, T. Y., Li, C. W., Tang, Y. Q., Ma, N. F., & Liu, M. (2023). Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery. Journal of Visualized Experiments. https://doi.org/10.3791/65785

Vancouver

Zhang CY, Zhang XF, Yuan J, Gong YF, Tang H, Guo WY, et al. Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery. Journal of Visualized Experiments. 2023. doi:10.3791/65785

BibTeX
@article{Zhang2023,
  author = {Zhang, Cheng-Yang and Zhang, Xiao-Feng and Yuan, Jun and Gong, Yuan-Feng and Tang, Hui and Guo, Wan-Yu and Li, Tong-Yan and Li, Cai-Wen and Tang, Yun-Qiang and Ma, Ning-Fang and Liu, Ming},
  title = {Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/65785}
}
Start for free →